This Symposium was coordinated by the Stem Cell & Regenerative Medicine Center, at the University of Wisconsin-Madison and the BTC Institute. It brought together leading researchers advancing human pluripotent stem cell products to clinical applications for a range of degenerative diseases. Progress in clinical trials was highlighted and major barriers for developing these revolutionary new therapies were also discussed.

highlighted issues
  • Human pluripotent stem cell therapies for diabetes, ocular disease, spinal cord injury, Parkinson’s disease, and heart failure
  • Biomanufacturing of clinical grade cellular products
  • Overcoming immunological barriers for human pluripotent stem cell-based therapies
  • Defining safe and effective human pluripotent stem cell clinical products
schedule
ABSTRACTS
Poster Abstracts

Congratulations to our Poster Contest winners:
1st Place: Brett Napiwocki
2nd Place: Clarisse Fligor
3rd Place: Angela Xie

ARCHIVE
presenters

Kapil Bharti, Ph.D., Stadtman Investigator, Unit on Ocular Stem Cell & Translational Research, National Eye Institute, National Institutes of Health, Bethesda, MD

Dennis Clegg, Ph.D., Professor, Wilcox Family Chair in BioMedicine, Molecular, Cellular, and Developmental Biology, University of California, Santa Barbara, Santa Barbara, CA

Derek Hei, Ph.D., VP Manufacturing, Quality, and Regulatory, BlueRock Therapeutics, Cambridge, MA

Jane Lebkowski, Ph.D., President of R & D and Chief Scientific Officer, Asterias Biotherapeutics, Fremont, CA

Richard McFarland, M.D., Ph.D., Chief Regulatory Officer, Advanced Regenerative Manufacturing Institute, Manchester, NH

Philippe Menasché, M.D., Ph.D., Professor of Thoracic and Cardiovascular Surgery, University of Paris Descartes; Chief of the Heart Failure Surgery Unit, Hôpital Européen Georges Pompidou, Paris, France

Felicia Pagliuca, Ph.D., Scientific Co-Founder, Vice President of Cell Biology Research and Development, Semma Therapeutics, Cambridge, MA

David Russell, M.D., Ph.D., Professor of Medicine, Division of Hematology; Adjunct Professor of Biochemistry, University of Washington School of Medicine, Seattle, WA

Lorenz Studer, M.D., Director, Memorial Sloan-Kettering Center for Stem Cell Biology; Professor, Department of Neuroscience, Weill-Cornell Graduate School, New York, NY

MODERATORS

* Indicates also serving as a Poster Judge

*Marina E. Emborg, M.D., Ph.D., Professor, Medical Physics, University of Wisconsin School of Medicine and Public Health, Madison, WI

*David M. Gamm, M.D., Ph.D., Associate Professor, Opthamology & Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI

*Timothy J. Kamp, M.D., Professor, Medicine, Cell and Regenerative Biology; Co-director, Stem Cell and Regenerative Medicine Center, University of Wisconsin–Madison, Madison, WI

William L. Murphy, Ph.D., Professor, Biomedical Engineering, Orthopedics & Rehabilitation; Co-director, Stem Cell & Regenerative Medicine Center, University of Wisconsin–Madison, Madison, WI

*Jon S. Odorico, M.D., Professor, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI

James Thomson, Ph.D., John D. MacArthur Professor, Director, Regenerative Biology, Morgridge Institute for Research, University of Wisconsin – Madison, Madison, WI; Professor, Department of Molecular, Cellular, & Developmental Biology, University of California – Santa Barbara, Santa Barbara, CA

LOCATION: BioParmaceutical Technology Center, 5445 East Cheryl Parkway, Madison, WI
DIRECTIONS